MICHELLE MCCLOSKEY: Open Payments
NPI 1598010605 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 15 payments from 9 companies in 2025. Trend: 2023 $2,160 · 2024 $1,451 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $163 |
| SI-BONE, INC. | 1 | $130 |
| Edwards Lifesciences Corporation | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $123 |
| Globus Medical, Inc. | 4 | $87 |
| Boston Scientific Corporation | 3 | $83 |
| Eisai Inc. | 2 | $42 |
| Averitas Pharma Inc. | 1 | $27 |
Products named: DEXCOM G7 GSS (161), REZDIFFRA, Senza, Intracept, Lenvima, Intracept RF Probe, QUTENZA, OMNIA.
Industry payments across LA — which companies pay providers there.
